Matching-Adjusted Indirect Comparison (Maic) Of Axicabtagene Ciloleucel (Axi-Cel) And Epcoritamab (Epcor) In Relapsed/Refractory (R/R) Large B Cell Lymphoma (Lbcl) After At Least Two Prior Systemic Therapies (3L+)
Axicabtagene Ciloleucel;Epcoritamab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Matching-Adjusted Indirect Comparison (Maic) Of Axicabtagene Ciloleucel (Axi-Cel) And Epcoritamab (Epcor) In Relapsed/Refractory (R/R) Large B Cell Lymphoma (Lbcl) After At Least Two Prior Systemic Therapies (3L+) ### Output: Axicabtagene Ciloleucel;Epcoritamab